Sulfisoxazole → 1-Cyclohexyl-3-[4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulfamoyl]phenyl]urea

HRID 1899690

Reaktionsgleichung

Reaktionsgleichung von HRID 1899690
[NH2:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([NH:11][C:12]2[O:16][N:15]=[C:14]([CH3:17])[C:13]=2[CH3:18])(=[O:10])=[O:9])=[CH:4][CH:3]=1.[CH:19]1([N:25]=[C:26]=[O:27])[CH2:24][CH2:23][CH2:22][CH2:21][CH2:20]1>>[CH:19]1([NH:25][C:26](=[O:27])[NH:1][C:2]2[CH:7]=[CH:6][C:5]([S:8]([NH:11][C:12]3[O:16][N:15]=[C:14]([CH3:17])[C:13]=3[CH3:18])(=[O:10])=[O:9])=[CH:4][CH:3]=2)[CH2:24][CH2:23][CH2:22][CH2:21][CH2:20]1

Komponenten

3

Edukt 2

HCID 5344SulfisoxazoleHCID 18502Cyclohexyl isocyanate

Produkt 1

HCID 40545201-Cyclohexyl-3-[4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulfamoyl]phenyl]urea

Versuchsvorschrift

This compound was prepared from 4-amino-N-(3,4-dimethyl-5-isoxazolyl)benzene-sulfonamide and cyclohexyl isocyanate according to the method in Example 110 in 75% crude yield. Further purification was achieved by preparative HPLC (76% recovery), furnishing the pure product as a white solid, m.p. 190°-195° C.

Aufarbeitung

  1. customFurther purification

Quellen und Nachweise

ORD-Eintrag
ord-038f879dac3c45869fa859d2befa14a5
Quelldatensatz
uspto-grants-1996_11
Patentnummer
US05571821

Verknüpfte Notizen

Wird geladen…